Johnson & Johnson

JNJ · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

1.339%

12M weight contribution

-0.179 pp

3M weight contribution

+0.344 pp

12M price return

+3.1%

Share of matched S&P 500 members

Monthly observations through Aug 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Aug 2023	$420.2bn	1.339%	-0.179 pp	+3.1%	Yes
Jul 2023	$435.4bn	0.949%	-0.628 pp	-1.3%	No
Jun 2023	$430.1bn	0.995%	-0.822 pp	-4.1%	No
May 2023	$403.0bn	0.995%	-0.706 pp	-11.2%	No
Apr 2023	$425.4bn	1.437%	-0.280 pp	-6.8%	No
Mar 2023	$403.7bn	1.377%	-0.191 pp	-10.2%	No
Feb 2023	$399.1bn	1.403%	-0.098 pp	-4.4%	No
Jan 2023	$427.3bn	1.462%	-0.063 pp	-2.7%	No
Dec 2022	$461.8bn	1.667%	+0.224 pp	+6.0%	Yes
Nov 2022	$465.4bn	1.579%	+0.192 pp	+17.2%	No
Oct 2022	$454.8bn	1.614%	+0.182 pp	+9.6%	No
Sep 2022	$429.5bn	1.688%	+0.195 pp	+3.8%	Yes
Aug 2022	$424.2bn	1.518%	-0.006 pp	-4.4%	No
Jul 2022	$458.8bn	1.577%	+0.022 pp	+3.9%	No
Jun 2022	$467.1bn	1.817%	+0.285 pp	+10.5%	Yes
May 2022	$472.4bn	1.701%	+0.105 pp	+8.8%	Yes
Apr 2022	$474.9bn	1.717%	+0.164 pp	+13.7%	Yes
Mar 2022	$466.0bn	1.568%	+0.724 pp	+10.6%	Yes
Feb 2022	$432.7bn	1.501%	+0.668 pp	+6.5%	Yes
Jan 2022	$453.6bn	1.525%	+0.497 pp	+8.3%	Yes
Dec 2021	$450.4bn	1.443%	-0.234 pp	+11.4%	No
Nov 2021	$410.5bn	1.387%	-0.231 pp	+10.5%	No
Oct 2021	$428.8bn	1.432%	-0.277 pp	+21.8%	No
Sep 2021	$425.1bn	1.493%	+1.491 pp	+11.3%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.